OABI FY 2023 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M-42.2% YoY

Gross Profit

$34M100.0% margin

Operating Income

-$69M-203.2% margin

Net Income

-$51M-148.2% margin

EPS (Diluted)

$-0.51

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$703,000

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$375M

Total Liabilities

$61M

Stockholders' Equity

$315M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$59M	-42.2%
Gross Profit	$34M	$59M	-42.2%
Operating Income	-$69M	-$27M	-160.5%
Net Income	-$51M	-$22M	-126.6%